EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HPV is an essential driver in recurrence of cervical cancer

Sara Bønløkke, Magnus Stougaard, Jan Blaakær, Jesper Bertelsen, Karoline Andersen, Katrine Fuglsang, Torben Steiniche

Pathology - Research and Practice · 2024

DOI: 10.1016/j.prp.2024.155672 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology - Research and Practice, 2024. Verfasst von Sara Bønløkke und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine, Aarhus University, Aarhus N, Denmark; Department of Pathology, Aarhus University Hospital, Aarhus N, Denmark. Electr…. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Infections, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vissing Foundation, Harboe Foundation, KV Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: High-risk human papillomavirus (HPV) has been detected in distant metastases from cervical cancer (CC) patients, suggesting a role of HPV. MATERIAL AND METHODS: Here, we included 26 patients with recurrence of CC (2019-2023). With next generation sequencing (NGS) and immunohistochemical staining, primary and recurrent tissues were analyzed for HPV DNA and HPV RNA, p16INK4a expression, and somatic TP53 and RB1 mutations. RESULTS: All primary and corresponding recurrent tissues were HPV DNA and HPV RNA positive. Within the same tissue, we found complete DNA/RNA agreement in 25/26 (96.2 %) primary and 25/25 (100 %) recurrent tissues, and partial agreement in the remaining sample. There was complete agreement between primary and recurrent tissue in 23/26 (88.5 %) and 23/25 (92.0 %) patients on DNA and RNA, respectively, whereas the remaining showed partial agreement with two genotypes detected in primary and only one of these in recurrent tissue. Except for one sample, all samples from high-risk HPV-positive patients were p16INK4a positive. The low-risk HPV11-positive patient was p16INK4a negative and had a pathogenic TP53 mutation, while the remaining samples were TP53/RB1 mutation negative. CONCLUSION: In high-risk HPV-positive CC patients, HPV seems to play a role in recurrent disease. Our findings support ongoing research on targeting HPV oncogenes in CC, also in metastatic disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsPapillomavirus InfectionsNeoplasm Recurrence, LocalHumansFemaleMiddle AgedAdultAgedTumor Suppressor Protein p53PapillomaviridaeCyclin-Dependent Kinase Inhibitor p16MutationRetinoblastoma Binding ProteinsUbiquitin-Protein Ligases

Stichwörter der Autor:innen

Cervical cancerHPV oncogenesRecurrenceTP53 mutationp16(INK4a)

Substanzen

Tumor Suppressor Protein p53Cyclin-Dependent Kinase Inhibitor p16Retinoblastoma Binding ProteinsTP53 protein, humanRB1 protein, humanCDKN2A protein, humanUbiquitin-Protein Ligases

Autor:innen und Institutionen

  • Department of Clinical Medicine, Aarhus University, Aarhus N, Denmark; Department of Pathology, Aarhus University Hospital, Aarhus N, Denmark. Electronic address: sarasim@clin.au.dk.
  • Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark. Electronic address: magnstou@rm.dk.
  • Department of Obstetrics and Gynecology, Odense University Hospital, Odense C, Denmark; Department of Clinical Research, University of Southern Denmark, Odense M, Denmark. Electronic address: jan.blaakaer@rsyd.dk.
  • Department of Clinical Medicine, Aarhus University, Aarhus N, Denmark; Department of Pathology, Aarhus University Hospital, Aarhus N, Denmark. Electronic address: jesber@rm.dk.
  • Department of Clinical Medicine, Aarhus University, Aarhus N, Denmark; Department of Pathology, Aarhus University Hospital, Aarhus N, Denmark. Electronic address: kaan@clin.au.dk.
  • Department of Clinical Medicine, Aarhus University, Aarhus N, Denmark; Department of Obstetrics and Gynecology, Aarhus University Hospital, Aarhus N, Denmark. Electronic address: katrfugl@rm.dk.

Förderung

  • Vissing Foundation
  • Harboe Foundation
  • KV Foundation
  • Fabrikant Einar Willumsens Mindelegat
  • Aase and Ejnar Danielsens Foundation
  • Inge and Jørgen Larsens Memorial Scholarship
  • Engineer Frode V Nyegaard and Wife's Foundation
  • Engineer K A Rohde and Wife Scholarship

Zitieren

APA

Bønløkke, S., Stougaard, M., Blaakær, J., Bertelsen, J., Andersen, K., Fuglsang, K., & Steiniche, T. (2024). HPV is an essential driver in recurrence of cervical cancer. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2024.155672

Vancouver

Bønløkke S, Stougaard M, Blaakær J, Bertelsen J, Andersen K, Fuglsang K, et al. HPV is an essential driver in recurrence of cervical cancer. Pathology - Research and Practice. 2024. doi:10.1016/j.prp.2024.155672

BibTeX
@article{Bnlkke2024,
  author = {Bønløkke, Sara and Stougaard, Magnus and Blaakær, Jan and Bertelsen, Jesper and Andersen, Karoline and Fuglsang, Katrine and Steiniche, Torben},
  title = {HPV is an essential driver in recurrence of cervical cancer},
  journal = {Pathology - Research and Practice},
  year = {2024},
  doi = {10.1016/j.prp.2024.155672}
}
Kostenlos starten →